<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00740220</url>
  </required_header>
  <id_info>
    <org_study_id>BG02-489</org_study_id>
    <nct_id>NCT00740220</nct_id>
  </id_info>
  <brief_title>Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation</brief_title>
  <acronym>6MWT</acronym>
  <official_title>Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will test the hypothesis that the 6 minute walk test (6MWT) is not reproducible as
      a measure for oxygen desaturation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over 16 million adults in the United States are afflicted with chronic obstructive pulmonary
      disease (COPD) and is the fourth leading cause of death.(McCrory et al. 1190-209). COPD
      accounts for direct health-care costs of $18 billion.(McCrory et al. 1190-209). Oxygen
      therapy has been shown to decrease mortality in COPD patients with severe hypoxemia at rest.
      Oxygen therapy now accounts for the number one expenditure for durable medical equipment.
      Current requirements for oxygen therapy for COPD patients include a resting or exercise paO2
      or spO2 of 55 mmHg or 88% respectively. We have shown that a resting spO2 of &lt; 95% is
      predictive of those at risk of exercise induced hypoxemia in COPD patients(Knower et al.
      732-36) based on continuous spO2 monitoring during a 6 minute walk. Although, the
      reproducibility of a 6 minute walk has been addressed in terms of a hospital test, simulated
      home test and actual home test (Guyatt), its inter-variability is not well studied.

      We propose to investigate the reliability and inter-variability of the 6 minute walk for
      oxygen prescription. Currently, two programs are providing pulmonary rehabilitation for COPD
      patients in the community. Patients perform 6 minute walks under supervision and are
      monitored by pulse oximetry on a routine basis as part of these programs. We plan to capture
      the oximetry data in order to determine the reliability of oxygen prescriptions using the 6
      minute walk. Patients who are performing a 6 minute walk will be eligible for enrollment.
      Protocols for the 6 minute walk are already in place and approved by their respective
      authority in both of the Pulmonary Rehabilitation Programs. These patients will have repeat 6
      minute walks on separate in close proximity to determine the reliability of spO2 on any given
      day. Statistical analysis will be done by the kappa statistic for inter-test agreement in a 3
      dimensional matrix.

      We ask to waive consent for this study as there is no change to the daily routine of the 6
      minute walks already being done as part of Pulmonary Rehabilitation. We plan only to capture
      the data from these walks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Kappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)</measure>
    <time_frame>All three 6MWTs should take place within 30 days</time_frame>
    <description>The kappa statistic is a measure of the quality of a test. It is a ratio.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">97</enrollment>
  <condition>Hypoxemia</condition>
  <condition>Anoxia</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <description>Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be carried out in a population of subjects who are taking part in Pulmonary
        Rehabilitation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Taking part in Pulmonary Rehabilitation

        Exclusion Criteria:

          -  Inability to perform 6MWT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arjun B Chatterjee, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Guyatt GH, McKim DA, Weaver B, Austin PA, Bryan RE, Walter SD, Nonoyama ML, Ferreira IM, Goldstein RS. Development and testing of formal protocols for oxygen prescribing. Am J Respir Crit Care Med. 2001 Mar;163(4):942-6.</citation>
    <PMID>11282770</PMID>
  </reference>
  <reference>
    <citation>Knower MT, Dunagan DP, Adair NE, Chin R Jr. Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2001 Mar 12;161(5):732-6.</citation>
    <PMID>11231707</PMID>
  </reference>
  <reference>
    <citation>McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest. 2001 Apr;119(4):1190-209.</citation>
    <PMID>11296189</PMID>
  </reference>
  <reference>
    <citation>Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981 Mar 28;1(8222):681-6.</citation>
    <PMID>6110912</PMID>
  </reference>
  <reference>
    <citation>Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980 Sep;93(3):391-8.</citation>
    <PMID>6776858</PMID>
  </reference>
  <reference>
    <citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. Erratum in: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.</citation>
    <PMID>12091180</PMID>
  </reference>
  <reference>
    <citation>Bradley JM, O'Neill B. Short-term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004356. Review.</citation>
    <PMID>16235359</PMID>
  </reference>
  <reference>
    <citation>Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Ja√≠me A, Vassaux C, Celli BR. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008 Oct;134(4):746-52. doi: 10.1378/chest.08-0520. Epub 2008 Jul 14.</citation>
    <PMID>18625667</PMID>
  </reference>
  <reference>
    <citation>Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004 Mar 4;350(10):1005-12.</citation>
    <PMID>14999112</PMID>
  </reference>
  <reference>
    <citation>Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med. 2006 Aug 15;174(4):373-8. Epub 2006 Apr 13.</citation>
    <PMID>16614349</PMID>
  </reference>
  <reference>
    <citation>Drummond MB, Blackford AL, Benditt JO, Make BJ, Sciurba FC, McCormack MC, Martinez FJ, Fessler HE, Fishman AP, Wise RA; NETT Investigators. Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest. 2008 Sep;134(3):497-506. doi: 10.1378/chest.08-0117. Epub 2008 Jul 18.</citation>
    <PMID>18641094</PMID>
  </reference>
  <reference>
    <citation>Dunne PJ. The demographics and economics of long-term oxygen therapy. Respir Care. 2000 Feb;45(2):223-8; discussion 228-30. Review.</citation>
    <PMID>10771794</PMID>
  </reference>
  <reference>
    <citation>Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005 May 15;171(10):1150-7. Epub 2005 Jan 7.</citation>
    <PMID>15640367</PMID>
  </reference>
  <reference>
    <citation>Eiser N, Willsher D, Dor√© CJ. Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir Med. 2003 Apr;97(4):407-14.</citation>
    <PMID>12693802</PMID>
  </reference>
  <reference>
    <citation>Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003 Nov 1;168(9):1034-42. Epub 2003 Jul 17.</citation>
    <PMID>12869359</PMID>
  </reference>
  <reference>
    <citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7.</citation>
    <PMID>9817683</PMID>
  </reference>
  <reference>
    <citation>Escourrou PJ, Delaperche MF, Visseaux A. Reliability of pulse oximetry during exercise in pulmonary patients. Chest. 1990 Mar;97(3):635-8.</citation>
    <PMID>2106411</PMID>
  </reference>
  <reference>
    <citation>Garc√≠a-Talavera I, Garc√≠a CH, Macario CC, de Torres JP, Celli BR, Aguirre-Jaime A. Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg. Respir Med. 2008 Jul;102(7):1026-32. doi: 10.1016/j.rmed.2008.02.004. Epub 2008 Mar 17.</citation>
    <PMID>18343649</PMID>
  </reference>
  <reference>
    <citation>Guyatt GH, Nonoyama M, Lacchetti C, Goeree R, McKim D, Heels-Ansdell D, Goldstein R. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med. 2005 Sep 1;172(5):573-80. Epub 2005 May 18.</citation>
    <PMID>15901604</PMID>
  </reference>
  <reference>
    <citation>Guyatt GH, McKim DA, Austin P, Bryan R, Norgren J, Weaver B, Goldstein RS. Appropriateness of domiciliary oxygen delivery. Chest. 2000 Nov;118(5):1303-8.</citation>
    <PMID>11083678</PMID>
  </reference>
  <reference>
    <citation>Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest. 2001 Jul;120(1):88-92.</citation>
    <PMID>11451821</PMID>
  </reference>
  <reference>
    <citation>Lewis CA, Eaton TE, Fergusson W, Whyte KF, Garrett JE, Kolbe J. Home overnight pulse oximetry in patients with COPD: more than one recording may be needed. Chest. 2003 Apr;123(4):1127-33.</citation>
    <PMID>12684303</PMID>
  </reference>
  <reference>
    <citation>MacIntyre NR. Oxygen therapy and exercise response in lung disease. Respir Care. 2000 Feb;45(2):194-200; discussion 201-3. Review.</citation>
    <PMID>10771791</PMID>
  </reference>
  <reference>
    <citation>Mak VH, Bugler JR, Roberts CM, Spiro SG. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax. 1993 Jan;48(1):33-8.</citation>
    <PMID>8434350</PMID>
  </reference>
  <reference>
    <citation>McGovern JP, Sasse SA, Stansbury DW, Causing LA, Light RW. Comparison of oxygen saturation by pulse oximetry and co-oximetry during exercise testing in patients with COPD. Chest. 1996 May;109(5):1151-5.</citation>
    <PMID>8625659</PMID>
  </reference>
  <reference>
    <citation>O'Donohue WJ Jr, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest. 1995 Feb;107(2):301-2.</citation>
    <PMID>7842750</PMID>
  </reference>
  <reference>
    <citation>Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Pr√©faut C. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003 May;123(5):1401-7.</citation>
    <PMID>12740254</PMID>
  </reference>
  <reference>
    <citation>Romagnoli M, Dell'Orso D, Lorenzi C, Crisafulli E, Costi S, Lugli D, Clini EM. Repeated pulmonary rehabilitation in severe and disabled COPD patients. Respiration. 2006;73(6):769-76. Epub 2006 Apr 21.</citation>
    <PMID>16636528</PMID>
  </reference>
  <reference>
    <citation>Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J. 1997 Jun;10(6):1278-84.</citation>
    <PMID>9192929</PMID>
  </reference>
  <reference>
    <citation>Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, Wise RA; National Emphysema Treatment Trial Research Group. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003 Jun 1;167(11):1522-7. Epub 2003 Feb 20.</citation>
    <PMID>12615634</PMID>
  </reference>
  <reference>
    <citation>Timms RM, Kvale PA, Anthonisen NR, Boylen CT, Cugell DW, Petty TL, Williams GW. Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. JAMA. 1981 Jun 26;245(24):2514-5.</citation>
    <PMID>7014957</PMID>
  </reference>
  <reference>
    <citation>Ram FS, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;(2):CD000238. Review. Update in: Cochrane Database Syst Rev. 2014;6:CD000238.</citation>
    <PMID>12076387</PMID>
  </reference>
  <reference>
    <citation>Zieli≈Ñski J, Tobiasz M, Hawry≈Çkiewicz I, Sliwi≈Ñski P, Pa≈Çasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest. 1998 Jan;113(1):65-70.</citation>
    <PMID>9440570</PMID>
  </reference>
  <reference>
    <citation>Budweiser S, Heidtkamp F, J√∂rres RA, Heinemann F, Arzt M, Schroll S, Schmidbauer K, Hitzl AP, Pfeifer M. Predictive significance of the six-minute walk distance for long-term survival in chronic hypercapnic respiratory failure. Respiration. 2008;75(4):418-26. Epub 2007 Oct 9.</citation>
    <PMID>17934248</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2008</study_first_submitted>
  <study_first_submitted_qc>August 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2008</study_first_posted>
  <results_first_submitted>February 13, 2009</results_first_submitted>
  <results_first_submitted_qc>March 13, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 20, 2009</results_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypoxemia</keyword>
  <keyword>anoxia</keyword>
  <keyword>oxygen</keyword>
  <keyword>dyspnea</keyword>
  <keyword>pulmonary disease</keyword>
  <keyword>chronic obstructive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data could only be shared if requestor had IRB approval and funding to re-contact all participants for permission.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Arm Prospective Observational Study</title>
          <description>Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested. These will all be subjects in Pulmonary Rehab.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>screen failures (non-COPD patients)</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm Prospective Observational Study</title>
          <description>Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested. These will all be subjects in Pulmonary Rehab.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="97"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Kappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)</title>
        <description>The kappa statistic is a measure of the quality of a test. It is a ratio.</description>
        <time_frame>All three 6MWTs should take place within 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Single Arm Prospective Observational Study</title>
            <description>Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested. These will all be subjects in Pulmonary Rehab.</description>
          </group>
        </group_list>
        <measure>
          <title>Kappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)</title>
          <description>The kappa statistic is a measure of the quality of a test. It is a ratio.</description>
          <units>Ratio</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Single Arm Prospective Observational Study</title>
          <description>Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested. These will all be subjects in Pulmonary Rehab.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="88"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was conducted in a Pulmonary Rehabilitation Population and may not be generalizable.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Arjun Chatterjee, MD, MS, FCCP</name_or_title>
      <organization>Wake Forest University</organization>
      <phone>336.716.4649</phone>
      <email>achatter@wfubmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

